Showing 251 - 260 of 758
China is building up its global competitiveness in knowledge-intensive sectors and its ambition to be a global leader in science and innovation by 2050 seems well within reach. China outperforms the European Union in terms of expenditure on research and development as a share of its GDP, and...
Persistent link: https://www.econbiz.de/10011738337
Persistent link: https://www.econbiz.de/10011698762
The European Union has prioritised the pursuit of innovation-based growth and targeting of resources to promote research and development, but performance on innovation remains weak. With the lack of results comes fatigue, waning interest and mounting criticism about policy. Should the EU abandon...
Persistent link: https://www.econbiz.de/10011406776
Persistent link: https://www.econbiz.de/10009892382
Persistent link: https://www.econbiz.de/10009892408
MRNA technology has proved in the context of the COVID-19 pandemic its breakthrough value as a basis for vaccines. There has been rapid development of highly safe, effective and robust mRNA vaccines, and these can be delivered at large scale. Yet the technology is the result of a long process of...
Persistent link: https://www.econbiz.de/10013184655
Persistent link: https://www.econbiz.de/10014532254
Empirical research on complementarity between organizational design decisions has traditionally focused on the question of existence of complementarity. In this paper, we take a broader approach to the issue, combining a "productivity" and an "adoption" approach, while including a search for...
Persistent link: https://www.econbiz.de/10009204237